In PCa cell lines, 4-OHE2 significantly upregulated IL6 expression, increased the proportion of CD44+/CD24− PCSCs, increased tumorsphere formation ability, and decreased bicalutamide sensitivity, while IL6 neutralizing antibodies reversed these effects. The gene discussed is IL6; the disease is posterior cortical atrophy.